Skip To The Main Content

PDA Europe Webinar - Rethinking Facility Design and Set-up for Vaccine Manufacturing

Nov 10, 2020
4:00 PM
5:30 PM
| Central Europe Standard Time
  • Webinar
  • Virtual
  • Online
  • Europe


Dear Colleagues,

For the past decade, science and industry had an urgent need to respond to outbreaks and pandemics of H1N1 Influenza, Ebola, MERS, Zika and now SARS-CoV-2 (COVID-19). Vaccines are the ultimate response to emerging diseases, but they typically take several years to develop and manufacturing large amounts of doses in an emergency is a major challenge. While lessons learned from past outbreaks and pandemics have made it possible to implement innovative changes in vaccine manufacturing and improve the response to a surge in vaccines, the current COVID-19 pandemic exposes remaining manufacturing and capacity issues. How can we rethink vaccine manufacturing to make it more efficient and faster? What are the manufacturing and plant design considerations when handling different vaccines in the same facility?

This webinar outlines some key considerations and perspectives on manufacturing evolution and in particular on facility and process design to change the vaccine manufacturing paradigm and improve our response to pandemics and global health challenges.

Topics will include:

• Overview of vaccine industry & vaccine types
• Challenges with pandemics and outbreaks
• Evolution of vaccine manufacturing in the last decade
• Perspectives on how vaccine production needs to be improved to better respond to emergencies
• Facility design considerations to handle multiple vaccines and to increase flexibility 

We look forward to seeing you online!



  • Welcome, Introduction to the Webinar Series Guido Kremer-van der Kamp, Merck KGaA
    Overview of Current Vaccine Manufacturing and Future Perspectives Anissa Boumlic, Merck KGaA
    Design Considerations for Vaccine Facilities Stefan Kappeler, Exyte
    Interactive Live Q&A and Discussion
    Viral Vector-based Vaccine Single Use Manufacturing Case Study Anissa Boumlic, Merck KGaA
    Final Discussion and Closing Remarks
    End of Webinar and Farewell

Highlighted Speakers

Anissa Boumlic
Anissa Boumlic
Merck KGaA
Stefan Kappeler
Stefan Kappeler
Exyte AG

Registration Fees

Register Now
Registration Type Price
All Participants €199

Got a Question? We have answers

Contact Us
Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information


Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Media Partners

PDA Members Save Substantially